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Abstract
Background: Primary carcinoid tumor of the gallbladder is rare and comprises less than 1% of all carcinoid tumors.
Preoperative diagnosis of carcinoid tumor of the gallbladder is difficult. The imageology findings are similar to
those in other gallbladder cancers.
Case presentation: A 46-year-old woman was hospitalized with a preoperative diagnosis of gallbladder carcinoma,
The patient was referred for surgical opinion and laparotomy was subsequently performed. A 4 × 5 cm mass was
found within the gallbladder, located on the free surface of the body and fundus of the gallbladder. Neither
metastases nor direct invasion to the liver was found. The entire mass and gallbladder were excised and intact.
Histologically, the tumor consisted of small oval cells with round-to-oval neclei and tumor cells formed small
nodular, trabeculare and acinar structures. The tumor showed moderate pleomorphism with scattered mitotic
figures, but no definite evidence of vascular permeation, perineural invasion or lymphatic permeation was seen.
The tumor cells invaded the mucosa extensively, and some penetrated the muscular layer but not through the
serosa of the gallbladder into the liver. Immunohistochemical studies revealed strong positive reaction for
chromogranin A and NSE. This lesion was proved to be a primary carcinoid tumor of the gallbladder. A brief
review of literature, clinical feature, pathology and treatment of this rare disease was discussed.
Conclusion: Primary carcinoid tumor of the gallbladder is uncommon. The definite diagnosis is often made on
histopathological results after surgery.
Background
Generally, carcinoid tumors are thought to arise from
embryonal neural crest cells and may occur anywhere
that these cells are found. For the most part they tend
to be associated with the gastrointestinal tract and
respiratory system; however, primary carcinoid tumors
of the gallbladder are rare and comprises less than 1%
of all carcinoid tumors. We herein present a classical
carcinoid tumor found in gallbladder of a 46-year-old
woman and review the relevant literature on this rare
entity.
Case Presentation
A 46-year-old woman was hospitalized with a 2-year
history of dull pain in the right upper abdomen. Her
appetite was normal and she had no history of diarrhea,
flushes or dyspnea. There was no pertinent past medical
or surgical history. On examination, she was well nour-
ished with stable vital signs, and no pallor, jaundice, or
significant lymphadenopathy. Abdominal examination
revealed no tenderness, organomegaly, or abnormal
mass.
Laboratory investigation revealed normal hematologi-
cal findings and serum electrolyte levels. The laboratory
data of Liver function were within normal limits. The
results of assays for tumor-associated antigen revealed
that the serum levels of CEA, CA-50, CA19-9 and
CA125 were within normal limits. Urine and stool rou-
tine examinations proved normal. Because of no suspi-
cion for the diagnosis of carcinoid tumor before
treatment, we did not measure the levels of the urinary
5-hydroxyindoleacetic acid (5HIAA) and plasma seroto-
nin. The chest X-ray revealed no unusual findings.
Abdominal ultrasound showed a 4.5 cm protruding tis-
sue mass in the body and fundus of the gallbladder
lumen (Fig. 1). This mass appeared to arise from the
wall of the gallbladder. Contrast-enhance abdominal
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computed tomography was performed and revealed a
high-density mass in the gallbladder on the atrial phase
(Fig. 2). Low-density lesions in the right hepatic lobe
were not detected. No evidences of calcification in the
mass and biliary dilatation were noted.
With a preoperative diagnosis of gallbladder carci-
noma, the patient was referred for surgical opinion and
laparotomy was subsequently performed. At laparotomy,
a 4 × 5 cm mass was found within the gallbladder,
located on the free surface of the body and fundus of
the gallbladder. Neither metastases nor direct invasion
to the liver was found. The entire mass and gallbladder
were excised and intact. Pathological findings were as
follows: On grass inspection of the operated material,
the gallbladder measured 10 × 6 × 5 cm, and had a
smooth external surface. On opening the specimen, an
intramural tumor 5 cm in diameter located in the free
wall of the body and fundus of the gallbladder (Fig. 3).
Histologically, the tumor was seen infiltrating into the
mucosa extensively, and some penetrated the muscular
layer but not through the serosa of the gallbladder into
the liver. The gallbladder with tumor was completely
excised with free resection margins. The tumor con-
sisted of nests of small oval cells with round-to-oval
neclei and these nests were separated from each other
by thin fibrovascular bands. The tumor showed moder-
ate pleomorphism with scattered mitotic figures, but no
definite evidence of vascular permeation, perineural
invasion or lymphatic permeation was seen (Fig. 4 and
Fig. 5). Immunohistochemical studies of paraffin
sections revealed strong positivity for chromogranin A
(Fig. 6) and neuron-specific enolase (NSE) (Fig. 7). It
was diagnosed as a classical carcinoid tumor of the gall-
bladder. After surgery, the patient had an uneventful
recovery without incident. No recurrent lesion was
found using abdominal ultrasound examination and CT
scan 12 months after cholecystectomy.
Discussion
Carcinoid tumors are relatively rare endocrine tumors
arising principally in the gastrointestinal tract, where it
comprises less than 2% of all primary gastrointestinal
Figure 1 Abdominal ultrasound examination showing a mass (arrow) in the gallbladder.
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tumors [1]. Primary carcinoid tumors are mostly found
in the appendix, jejunum and rectum. Less common
sites include the bronchial epithelium, duodenum, colon
and stomach. The gallbladder in particular is extremely
rare site for carcinoid. Sanders [2] reported only 7
tumors (0.2%) in the gallbladder among 3633 digestive
tract carcinoids. Godwin [3] also reported only one case
(0.04%) in the gallbladder among 2837 carcinoids. The
first primary carcinoid tumor of the gallbladder was
described by Joel in 1929 [4], and in our investigation to
date, only 47 cases of carcinoid tumor of the gallbladder,
including that of our patient, were reported in the world
English literature [5-14]. From published data including
our case, the age of patients ranged from 38 to 81 years
[12]. The sex distribution of these lesions paralleled that
of gallbladder carcinomas, with a marked female predo-
minance that accounts for 75% of cases in the largest
series to date [15]. The most common presentation
includes vague abdominal pain or discomfort and asso-
ciated cholelithiasis [16]. In most instances, they usually
lack specific symptoms. Only 3.3%-3.7% of gallbladder
carcinoid tumors manifest with carcinoid syndrome
[10-16]. Preoperative diagnosis of carcinoid tumor of
the gallbladder is difficult. The diagnosis is rarely made
by imageology, because most patients are with no speci-
fic symptoms and imageology findings are similar to
those in other gallbladder cancers. As in the present
case, a mass in the gallbladder was indentified but deter-
mination of histologic type of tumor and diagnosis to
differentiate from gallbladder adenocarcinoma is often
difficult. Most carcinoids of the gallbladder were diag-
nosed incidentally upon routine histological examination
of gallbladder specimens at autopsy, after cholecystect-
omy for cholecystitis, or after surgical treatment of
patients in whom a biliary malignancy was suspected
[8-16]. Preoperative diagnosis of carcinoid tumor of the
gallbladder ordinarily is not possible because of its lack
of specific imaging findings.
Mizukami et al [8] and Kaiho et al [9] described in
detail the hallmark pathological findings that distinguish
the “classical” carcinoid tumors from their “carcinoma-
tous” counterparts. Classical carcinoids of the
Figure 2 An abdominal CT scan showing a mass (arrow) at the lumen of gallbladder.
Zou et al. World Journal of Surgical Oncology 2010, 8:12
http://www.wjso.com/content/8/1/12
Page 3 of 8
gallbladder have neither a metastatic nor invasive char-
acter and exhibit a more propitious prognosis. The “aty-
pical” variants, however, are associated with marked cell
atypia and mitosis, as well as a poor prognosis. From
histological analysis, Soga [16] found that 100% of typi-
cal carcinoid tumors stain positive for chromogranin A
and 93.8% of them stain positive for NSE. In our case,
the tumor consisted of small oval cells with round-to-
oval neclei and tumor cells formed small nodular, trabe-
culare and acinar structures. The tumor showed moder-
ate pleomorphism with scattered mitotic figures. The
tumor cells invaded the mucosa extensively, and some
penetrated the muscular layer but not through the ser-
osa of the gallbladder into the liver. Strong positive
reactions for chromogranin A and NSE were observed
in almost all tumor cells in the lesion. We think that
our case should be diagnosed as a classical carcinoid
tumor of the gallbladder.
The majority of reported patients underwent surgery.
Surgical strategies have varied from simple cholecystect-
omy (including laparoscopic cholecystectomy) to exten-
sive hepatic lebectomy, which depended on the size and
stage of the lesion, and particularly whether liver metas-
tases were present [5-14]. The SEER database from
Figure 3 Resected specimen of the gallbladder presenting a tumor (arrow) in the body and fundus of the gallbladder.
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Figure 4 Hematoxylin & eosin staining showing the tumor cells invaded the mucosa extensively and partially penetrated the
muscular layer (original magnification × 4).
Figure 5 Hematoxylin & eosin staining showing the tumor consisted of nests of small oval cells with round-to-oval neclei. Plenty of
vascular channels seen between the tumor cells (original magnification × 20).
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1992-1999 indicated that 82.4% of gallbladder carcinoids
remain localized and only 11.8% of patients were found
with distant metastases [15]. Although some lesions
were removed laparoscopically [11], some authors have
expressed reservations with regard to laparoscopic exci-
sion of gallbladder malignancies since it carries a high
risk of port metastases and dissemination [17]. With
this consideration, we performed the open cholecystect-
omy in our case. There is no general agreement on
when, or even if, chemotherapy should be started in
patients with malignant carcinoid. Conventional che-
motherapy including doxorubicin,5-fluorouracil, cispla-
tin, and streptozocin has minimal efficacy but may have
some utility in undifferentiated or highly proliferating
neuroendocrine carcinomas. Biotherapy using somatos-
tatin analogs such as octreotide or lanreotide have been
assessed in treatment of metastatic disease and remain
the only effective pharmacotherapeutic option that
improves symptomatology and quality of life with mini-
mal adverse effects [18,19]. The conclusive long-term
survival data are limited by the small patient population.
Soga [16] collected 138 cases of primary endocrinomas
of the gallbladder from the international sources. The
results of statistical evaluation showed that the cumula-
tive five-year-survival rate of carcinoid group was 60.4%.
From the SEER data (1992-1999), the five-year survival
was 58.8 ± 13.3% [15].
Specific prognostic factors have not been identified in
patients with gallbladder carcinoids, but increasing
tumor size, depth of invasion and metastasis are prob-
ably associated with the prognosis [10,16]. Therefore, to
improve the prognosis of carcinoid tumor of the gall-
bladder, it is important to detect the tumor at an early
stage and perform curative resection as soon as possible.
Although, the study of neuroendocrine tumors has
been advanced significantly by the elucidation of aspects
of carcinoid biology and the development of novel diag-
nostic methodology, there appears to be little change in
terms of outcome. The current optimal therapeutic
strategy for carcinoid tumors should be based on the
appreciation of the obviously malignant yet somewhat
restrained biologic behavior of these lesions. It is
Figure 6 The tumor cells were diffusely positive for chromogranin A stain (Chromogranin A stain, ×40).
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suggested that the future of the elucidation of this dis-
ease process requires correlation with precise cellular
and biologic determinants of malignancy as well as deli-
neation of the specific cell of origin and its precise
genomic configuration [15]. It will facilitate predictions
of the rate of tumor growth and the likelihood of meta-
static dissemination, thus allowing optimization of ther-
apeutic intervention.
Conclusion
Primary carcinoid tumor of the gallbladder is uncom-
mon. It is difficult to differentiate from adenocarci-
noma of the gallbladder preoperatively. The definite
diagnosis is often made on histopathological results
after surgery.
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